A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations

Tuberculosis (TB) was the predominant cause of death from a single infectious agent worldwide before the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. Although TB vaccines have been successfully used for about 100 years, their full effect is still unknown. In previous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapolnik, Paweł, Kmiecik, Wojciech, Nowakowska, Anna, Krzych, Łukasz Jerzy, Szymański, Henryk, Stopyra, Lidia, Jackowska, Teresa, Darmochwał-Kolarz, Dorota, Mazur, Artur, Czajka, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867106/
https://www.ncbi.nlm.nih.gov/pubmed/36679920
http://dx.doi.org/10.3390/vaccines11010075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867106/
https://www.ncbi.nlm.nih.gov/pubmed/36679920
http://dx.doi.org/10.3390/vaccines11010075

Ejemplares similares